Search results for "SYSTEMS"

showing 10 items of 11952 documents

Smart and resilient manufacturing in the wake of COVID-19.

2021

Since 2020, manufacturers have been facing unprecedented and extraordinary challenges with the COVID-19 outbreak, which severely disrupted manufacturing operations around the world. Some manufac- turers have shifted gears to help address dire shortages during the coronavirus pandemic. Others were thrown into deep unknowns and faced with the grim prospect of being closed down. We have seen a sprawling network of multinationals and local businesses step in to fill a void by using 3D printers to make personal protective equipment (PPE) such as face shields, respirator masks, nasal swabs and even ventilator parts. Large manufacturers attempted to rejig parts of their production lines to mass-pr…

2019-20 coronavirus outbreakHistoryEditorialCoronavirus disease 2019 (COVID-19)Hardware and ArchitectureControl and Systems EngineeringSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)WakeResilient manufacturing covid19VirologyIndustrial and Manufacturing EngineeringSoftwareJournal of manufacturing systems
researchProduct

Big data analytics in healthcare: a systematic literature review

2020

The current study performs a systematic literature review (SLR) to synthesise prior research on the  applicability of big data analytics (BDA) in healthcare. The SLR examines the outcomes of 41 stu...

2019-20 coronavirus outbreakInformation Systems and ManagementCoronavirus disease 2019 (COVID-19)Computer sciencebusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)05 social sciencesBig data02 engineering and technologyData scienceHealth informaticsComputer Science ApplicationsSystematic reviewAnalytics0502 economics and businessHealth care0202 electrical engineering electronic engineering information engineering020201 artificial intelligence & image processingbusiness050203 business & managementEnterprise Information Systems
researchProduct

Creativity and Innovation in Technology-Mediated Journalistic Work : Mapping out Enablers and Constraints

2020

This qualitative study examines creativity and innovation in dispersed, journalistic teams. Specifically, we study the factors enabling and constraining creativity and innovation in journalistic work in technology-mediated settings and explore how technology shapes these phenomena in dispersed journalistic teams. The study is motivated by the media industry’s heightened need for creativity and innovation as well as the changing nature of working life where an increasing amount of work is done via information and communication technologies. By closely examining two journalistic teams and their idea sharing and development processes, this study finds that successful creative work and innovati…

2019-20 coronavirus outbreakKnowledge managementCoronavirus disease 2019 (COVID-19)toimittajat (media)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)media_common.quotation_subjectComputerApplications_COMPUTERSINOTHERSYSTEMSComputingMilieux_LEGALASPECTSOFCOMPUTING050801 communication & media studiestechnology-mediated work0508 media and communications050602 political science & public administrationluovuusSociologydigitalisaatiocreativitymedia_commoninnovatiivisuusComputingMilieux_THECOMPUTINGPROFESSIONbusiness.industryCommunication05 social sciencesjournalistic practicesCreativitytiimityöinnovation0506 political scienceWork (electrical)media workjournalismiComputingMilieux_COMPUTERSANDSOCIETYbusinesspsychologically safe communication climateQualitative research
researchProduct

Atypical thrombosis associated with VaxZevria (R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

2021

The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during this health crisis. Although COVID-19 is a confounding factor per se, owing to its potential for multi-organ damage including the heart and kidney, the quality of the transmitted data in adverse drug reaction reports, the timeliness of feedback from clinicians, and the real-time pharmacological and medical analysis by the French network of the regional pharmacovigilance centers made it possible to s…

2019-20 coronavirus outbreakTime FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SDV]Life Sciences [q-bio]Letter to EditorAntiviral AgentsPharmacovigilancePharmacovigilancemedicineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)PandemicsComputingMilieux_MISCELLANEOUSCovid-19 vaccineSARS-CoV-2business.industryCOVID-19VaxZevria®medicine.diseaseAtypical thrombosisThrombosisVirology[SDV] Life Sciences [q-bio]Anti-PF4 antibodiesFrancebusinessThrombopenia
researchProduct

The Association of Schools of Public Health in the European Region Statement on the Erosion of Public Health Systems

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyEconomic growthStatement (logic)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Association (object-oriented programming)global healthPolitical scienceGlobal healthmedicinehealth systems strengtheningpublic health systemsglobal health securityCommunity and Home CarePublic healthpublic healthPublic Health Environmental and Occupational HealthCOVID-19European regionGlobal governanceglobal governanceSociety Journal ArchiveEditorialPublic aspects of medicineRA1-1270health systemsPublic Health Reviews
researchProduct

"Table 33" of "Measurement of the proton and deuteron structure functions, F2(p) and F2(d), and of the ratio sigma(L)/sigma(T)."

1997

Measurement of R=(SIG(L)/SIG(T)).

21.677ComputingMilieux_THECOMPUTINGPROFESSIONGeneralLiterature_INTRODUCTORYANDSURVEYInformationSystems_INFORMATIONINTERFACESANDPRESENTATION(e.g.HCI)Integrated Cross SectionMUON P --> MUON XRDeep Inelastic ScatteringCross SectionSIGMuon productionInclusiveInformationSystems_MODELSANDPRINCIPLESMUON DEUT --> MUON XInformationSystems_MISCELLANEOUS
researchProduct

PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions

2015

Nanocarriers of amphiphilic polymeric materials represent versatile delivery systems for poorly water soluble drugs. In this work the technique of solvent evaporation from multiple emulsions was applied to produce nanovectors based on new amphiphilic copolymer, the α,β-poly(N-2-hydroxyethyl)-DL-aspartamide-polylactic acid (PHEA-PLA), purposely synthesized to be used in the controlled release of active molecules poorly soluble in water. To this aim an amphiphilic derivative of PHEA, a hydrophilic polymer, was synthesized by derivatization of the polymeric backbone with hydrophobic grafts of polylactic acid (PLA). The achieved copolymer was thus used to produce nanoparticles loaded with α toc…

3003Biocompatible polymerPolymersChemistry PharmaceuticalDrug CompoundingPolyestersalpha-TocopherolPharmaceutical Sciencechemistry.chemical_compoundDrug Delivery SystemsNanoparticlePolylactic acidAmphiphileOrganic chemistryLactic AcidSolubilityDrug CarriersUltrasonic energyPHEA-PLAEmulsionAmphiphilic polymerControlled releaseSolventDrug LiberationSolubilitychemistryChemical engineeringDelayed-Action PreparationsDrug deliveryDrug deliverySolventsNanoparticlesEmulsionsNanocarriersPeptidesDrug carrierHydrophobic and Hydrophilic Interactions
researchProduct

Stabilization of unilamellar catanionic vesicles induced by β-cyclodextrins: A strategy for a tunable drug delivery depot.

2018

The limited stability of catanionic vesicles has discouraged their wide use for encapsulation and controlled release of active substances. Their structure can easily break down to form lamellar phases, micelles or rearrange into multilamellar vesicles, as a consequence of small changes in their composition. However, despite the limited stability, catanionic vesicles possess an attractive architecture, which is able to efficiently encapsulate both hydrophobic and hydrophilic molecules. Therefore, improving the stability of the vesicles, as well as the control on unilamellar structures, are prerequisites for their wider application range. This study focuses on the impact of β-cyclodextrins fo…

3003DepotPharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesMicelleDiffusionSurface-Active AgentsDrug Delivery SystemsCyclodextrinLamellar structureUnilamellar Liposomeschemistry.chemical_classificationCatanionic vesiclesCyclodextrinChemistryCetrimoniumVesiclebeta-Cyclodextrinstechnology industry and agricultureTemperatureSodium Dodecyl SulfateCatanionic vesicles; Cyclodextrin; Diffusion; NMR; Self-assembly; 3003Self-assembly021001 nanoscience & nanotechnologyCatanionic vesicleControlled releaseNMR0104 chemical sciencesChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryCetrimonium Compoundslipids (amino acids peptides and proteins)Self-assembly0210 nano-technologyInternational journal of pharmaceutics
researchProduct

Synchronizing the release rates of salicylate and indomethacin from degradable chitosan hydrogel and its optimization by definitive screening design.

2018

Abstract Three types of ionically crosslinked (with citric acid) chitosan discs were loaded with the highly water- soluble drug, sodium salicylate (SS) and the poorly water-soluble drug, indomethacin (Ind). In separate experiments the hydrated discs were immersed in a de-crosslinking solution comprising of different concentrations of calcium chloride, which induced a controlled erosion of the discs, a process which was optimized to synchronize the release rates of the two drugs over a predetermined period of time. The optimization was accomplished by manipulating six factors: chitosan MW, its amount in the formulation, the concentration of the crosslinker agent, the concentration of the de-…

3003DrugSynchronized release ratemedia_common.quotation_subjectIndomethacinPharmaceutical Sciencechemistry.chemical_elementmacromolecular substances02 engineering and technologyCalciumTriggered erosionCitric AcidChitosan03 medical and health scienceschemistry.chemical_compoundCrosslinked chitosan0302 clinical medicineDrug Delivery SystemsScreening designMultifactorial definitive screening designDissolutionSodium salicylatemedia_commonChitosanChromatographytechnology industry and agricultureHydrogelsCrosslinked chitosanDual drug platform021001 nanoscience & nanotechnologyDrug LiberationCross-Linking Reagentschemistry030220 oncology & carcinogenesisDrug Design0210 nano-technologyCitric acidSalicylic AcidEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Buccal drug delivery: what's new and what does the future hold?

2014

The buccal mucosa is the stratified squamous epithelial tissue inside lining of the cheeks. It is a favorable site of drug absorption since the tissue is non-keratinized, relatively immobile and strongly supplied with blood by a dense capillary-vessel network; moreover, it is highly tolerant to allergens, resistant to potentially harmful agents and has a relatively low enzymatic activity. The tissue consents quick onset of effect, offers an easily accessible and generally well-accepted site for drug delivery, is a useful route of administration in patients in an unconscious state (e.g., when swallowing is impaired), and is suitable for retentive dosage forms of administration. Buccal mucosa…

3003Drugmedia_common.quotation_subjectChemistry PharmaceuticalPharmaceutical ScienceDentistryPharmacologyDosage formRoute of administrationDrug Delivery SystemsPharmacokineticsMucositisMedicineAnimalsHumansBuccal dosage formmedia_commonDosage FormsDrug Carriersbusiness.industryLocoregional/systemic treatmentMedicine (all)Mouth MucosaAdministration BuccalTransmucosal deliveryBuccal administrationmedicine.diseaseBioavailabilityPharmaceutical PreparationsSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryBuccal mucosaDiffusion of InnovationbusinessForecastingTherapeutic delivery
researchProduct